Europe Onychomycosis Treatment Market 2021-2031 by Onychomycosis Type (Distal Subungual, White Superficial, Proximal Subungual, Candidal, Others), Treatment Type (Drug Treatment,

Europe onychomycosis treatment market was valued at $728.5 million in 2021 and will grow by 7.6% annually over 2021-2031, driven by the increasing prevalence of chronic medical ailments, the growing geriatric population, improved therapies and preventative solutions, and the rising healthcare expenditure.
Highlighted with 31 tables and 40 figures, this 94-page report “Europe Onychomycosis Treatment Market 2021-2031 by Onychomycosis Type (Distal Subungual, White Superficial, Proximal Subungual, Candidal, Others), Treatment Type (Drug Treatment, Laser Therapy, Photodynamic Therapy, Others), Distribution Channel (Hospitals and Clinics, Online Stores, Retail Pharmacies, Others), and Country: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire Europe onychomycosis treatment market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2018-2021 and provides forecast from 2022 till 2031 with 2021 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

In-depth qualitative analyses include identification and investigation of the following aspects:
• Market Structure
• Growth Drivers
• Restraints and Challenges
• Emerging Product Trends & Market Opportunities
• Porter’s Fiver Forces
The trend and outlook of Europe market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19 and the Russia-Ukraine conflict. The balanced (most likely) projection is used to quantify Europe onychomycosis treatment market in every aspect of the classification from perspectives of Onychomycosis Type, Treatment Type, Distribution Channel, and Country.

Based on Onychomycosis Type, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
• Distal Subungual Onychomycosis
• White Superficial Onychomycosis
• Proximal Subungual Onychomycosis
• Candidal Onychomycosis
• Other Onychomycosis Types

Based on Treatment Type, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
• Drug Treatment
• Laser Therapy
• Photodynamic Therapy
• Other Therapies

By Distribution Channel, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
• Hospitals and Clinics
• Online Stores
• Retail Pharmacies
• Other Distribution Channels

Geographically, the following national/local markets are fully investigated:
• Germany
• UK
• France
• Spain
• Italy
• Netherlands
• Rest of Europe (further segmented into Russia, Switzerland, Poland, Sweden, Belgium, Austria, Ireland, Norway, Denmark, and Finland)
For each key country, detailed analysis and data for annual revenue ($ mn) are available for 2021-2031. The breakdown of national markets by Onychomycosis Type, Treatment Type and Distribution Channel over the forecast years are also included.

The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.
Selected Key Players:
Bausch Health Companies Inc.
Bayer AG
Cipla Ltd
Dr. Reddys Laboratories Ltd
Galderma SA
GlaxoSmithKline PLC
Johnson & Johnson
Lumenis Ltd
Medimetriks Pharmaceuticals Inc.
Moberg Pharma AB
Novartis AG
Pfizer Inc.
Sanofi SA
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

1 Introduction 6
1.1 Industry Definition and Research Scope 6
1.1.1 Industry Definition 6
1.1.2 Research Scope 7
1.2 Research Methodology 10
1.2.1 Overview of Market Research Methodology 10
1.2.2 Market Assumption 11
1.2.3 Secondary Data 11
1.2.4 Primary Data 11
1.2.5 Data Filtration and Model Design 12
1.2.6 Market Size/Share Estimation 13
1.2.7 Research Limitations 14
1.3 Executive Summary 15
2 Market Overview and Dynamics 17
2.1 Market Size and Forecast 17
2.1.1 Impact of COVID-19 on World Economy 18
2.1.2 Impact of COVID-19 on the Market 20
2.2 Major Growth Drivers 22
2.3 Market Restraints and Challenges 29
2.4 Emerging Opportunities and Market Trends 32
2.5 Porter’s Fiver Forces Analysis 36
3 Segmentation of Europe Market by Onychomycosis Type 40
3.1 Market Overview by Onychomycosis Type 40
3.2 Distal Subungual Onychomycosis 42
3.3 White Superficial Onychomycosis 43
3.4 Proximal Subungual Onychomycosis 44
3.5 Candidal Onychomycosis 45
3.6 Other Onychomycosis Types 46
4 Segmentation of Europe Market by Treatment Type 47
4.1 Market Overview by Treatment Type 47
4.2 Drug Treatment 49
4.3 Laser Therapy 50
4.4 Photodynamic Therapy 51
4.5 Other Therapies 52
5 Segmentation of Europe Market by Distribution Channel 53
5.1 Market Overview by Distribution Channel 53
5.2 Hospitals and Clinics 55
5.3 Online Stores 56
5.4 Retail Pharmacies 57
5.5 Other Distribution Channels 58
6 European Market 2021-2031 by Country 59
6.1 Overview of European Market 59
6.2 Germany 62
6.3 U.K. 64
6.4 France 66
6.5 Spain 68
6.6 Italy 70
6.7 Netherlands 72
6.8 Rest of European Market 74
7 Competitive Landscape 76
7.1 Overview of Key Vendors 76
7.2 New Product Launch, Partnership, Investment, and M&A 79
7.3 Company Profiles 80
Bausch Health Companies Inc. 80
Bayer AG 82
Cipla Ltd 83
Dr. Reddys Laboratories Ltd 84
Galderma SA 85
GlaxoSmithKline PLC 86
Johnson & Johnson 87
Lumenis Ltd 88
Medimetriks Pharmaceuticals Inc. 89
Moberg Pharma AB 90
Novartis AG 91
Pfizer Inc. 92
Sanofi SA 93
RELATED REPORTS 94
 
List of Tables:

Table 1. Snapshot of Europe Onychomycosis Treatment Market in Balanced Perspective, 2021-2031 16
Table 2. World Economic Outlook, 2021-2031 19
Table 3. Clinical Trials of Onychomycosis Treatment 25
Table 4. World Health Spending by Region, $ bn, 2013-2020 28
Table 5. Main Product Trends and Market Opportunities in Europe Onychomycosis Treatment Market 32
Table 6. Europe Onychomycosis Treatment Market by Onychomycosis Type, 2021-2031, $ mn 40
Table 7. Europe Onychomycosis Treatment Market by Treatment Type, 2021-2031, $ mn 47
Table 8. Europe Onychomycosis Treatment Market by Distribution Channel, 2021-2031, $ mn 53
Table 9. Europe Onychomycosis Treatment Market by Country, 2021-2031, $ mn 61
Table 10. Germany Onychomycosis Treatment Market by Onychomycosis Type, 2021-2031, $ mn 63
Table 11. Germany Onychomycosis Treatment Market by Treatment Type, 2021-2031, $ mn 63
Table 12. Germany Onychomycosis Treatment Market by Distribution Channel, 2021-2031, $ mn 63
Table 13. U.K. Onychomycosis Treatment Market by Onychomycosis Type, 2021-2031, $ mn 65
Table 14. U.K. Onychomycosis Treatment Market by Treatment Type, 2021-2031, $ mn 65
Table 15. U.K. Onychomycosis Treatment Market by Distribution Channel, 2021-2031, $ mn 65
Table 16. France Onychomycosis Treatment Market by Onychomycosis Type, 2021-2031, $ mn 67
Table 17. France Onychomycosis Treatment Market by Treatment Type, 2021-2031, $ mn 67
Table 18. France Onychomycosis Treatment Market by Distribution Channel, 2021-2031, $ mn 67
Table 19. Spain Onychomycosis Treatment Market by Onychomycosis Type, 2021-2031, $ mn 69
Table 20. Spain Onychomycosis Treatment Market by Treatment Type, 2021-2031, $ mn 69
Table 21. Spain Onychomycosis Treatment Market by Distribution Channel, 2021-2031, $ mn 69
Table 22. Italy Onychomycosis Treatment Market by Onychomycosis Type, 2021-2031, $ mn 71
Table 23. Italy Onychomycosis Treatment Market by Treatment Type, 2021-2031, $ mn 71
Table 24. Italy Onychomycosis Treatment Market by Distribution Channel, 2021-2031, $ mn 71
Table 25. Netherlands Onychomycosis Treatment Market by Onychomycosis Type, 2021-2031, $ mn 73
Table 26. Netherlands Onychomycosis Treatment Market by Treatment Type, 2021-2031, $ mn 73
Table 27. Netherlands Onychomycosis Treatment Market by Distribution Channel, 2021-2031, $ mn 73
Table 28. Onychomycosis Treatment Market in Rest of Europe by Country, 2021-2031, $ mn 75
Table 29. Bausch Health Companies Inc.: Company Snapshot 80
Table 30. Bausch Health Companies Inc.: Business Segmentation 81
Table 31. Bausch Health Companies Inc.: Product Portfolio 81

List of Figures:

Figure 1. Research Method Flow Chart 10
Figure 2. Bottom-up Approach and Top-down Approach for Market Estimation 13
Figure 3. Europe Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2021-2031 15
Figure 4. Europe Onychomycosis Treatment Market, 2021-2031, $ mn 17
Figure 5. Impact of COVID-19 on Business 20
Figure 6. Primary Drivers and Impact Factors of Europe Onychomycosis Treatment Market 22
Figure 7. Worldwide Geriatric Population (60 years and above) by Regions, 2015 & 2030, million 26
Figure 8. World Population 65 and Over, % of Total Population, 1950-2060 27
Figure 9. Primary Restraints and Impact Factors of Europe Onychomycosis Treatment Market 29
Figure 10. Investment Opportunity Analysis 33
Figure 11. Porter’s Fiver Forces Analysis of Europe Onychomycosis Treatment Market 36
Figure 12. Breakdown of Europe Onychomycosis Treatment Market by Onychomycosis Type, 2021-2031, % of Revenue 41
Figure 13. Europe Addressable Market Cap in 2022-2031 by Onychomycosis Type, Value ($ mn) and Share (%) 41
Figure 14. Europe Onychomycosis Treatment Market by Onychomycosis Type: Distal Subungual Onychomycosis, 2021-2031, $ mn 42
Figure 15. Europe Onychomycosis Treatment Market by Onychomycosis Type: White Superficial Onychomycosis, 2021-2031, $ mn 43
Figure 16. Europe Onychomycosis Treatment Market by Onychomycosis Type: Proximal Subungual Onychomycosis, 2021-2031, $ mn 44
Figure 17. Europe Onychomycosis Treatment Market by Onychomycosis Type: Candidal Onychomycosis, 2021-2031, $ mn 45
Figure 18. Europe Onychomycosis Treatment Market by Onychomycosis Type: Other Onychomycosis Types, 2021-2031, $ mn 46
Figure 19. Breakdown of Europe Onychomycosis Treatment Market by Treatment Type, 2021-2031, % of Sales Revenue 48
Figure 20. Europe Addressable Market Cap in 2022-2031 by Treatment Type, Value ($ mn) and Share (%) 48
Figure 21. Europe Onychomycosis Treatment Market by Treatment Type: Drug Treatment, 2021-2031, $ mn 49
Figure 22. Europe Onychomycosis Treatment Market by Treatment Type: Laser Therapy, 2021-2031, $ mn 50
Figure 23. Europe Onychomycosis Treatment Market by Treatment Type: Photodynamic Therapy, 2021-2031, $ mn 51
Figure 24. Europe Onychomycosis Treatment Market by Treatment Type: Other Therapies, 2021-2031, $ mn 52
Figure 25. Breakdown of Europe Onychomycosis Treatment Market by Distribution Channel, 2021-2031, % of Sales Revenue 54
Figure 26. Europe Addressable Market Cap in 2022-2031 by Distribution Channel, Value ($ mn) and Share (%) 54
Figure 27. Europe Onychomycosis Treatment Market by Distribution Channel: Hospitals and Clinics, 2021-2031, $ mn 55
Figure 28. Europe Onychomycosis Treatment Market by Distribution Channel: Online Stores, 2021-2031, $ mn 56
Figure 29. Europe Onychomycosis Treatment Market by Distribution Channel: Retail Pharmacies, 2021-2031, $ mn 57
Figure 30. Europe Onychomycosis Treatment Market by Distribution Channel: Other Distribution Channels, 2021-2031, $ mn 58
Figure 31. Breakdown of European Onychomycosis Treatment Market by Country, 2021 and 2031, % of Revenue 60
Figure 32. Contribution to Europe 2022-2031 Cumulative Market by Country, Value ($ mn) and Share (%) 61
Figure 33. Onychomycosis Treatment Market in Germany, 2021-2031, $ mn 62
Figure 34. Onychomycosis Treatment Market in U.K., 2021-2031, $ mn 64
Figure 35. Onychomycosis Treatment Market in France, 2021-2031, $ mn 66
Figure 36. Onychomycosis Treatment Market in Spain, 2021-2031, $ mn 68
Figure 37. Onychomycosis Treatment Market in Italy, 2021-2031, $ mn 70
Figure 38. Onychomycosis Treatment Market in Netherlands, 2021-2031, $ mn 72
Figure 39. Onychomycosis Treatment Market in Rest of Europe, 2021-2031, $ mn 74
Figure 40. Growth Stage of Europe Onychomycosis Treatment Industry over the Forecast Period 76